Actively Recruiting
Study of Blood Cell Responses in Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis
Led by The Cleveland Clinic · Updated on 2026-09-24
30
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the inflammatory and mitochondrial responses in people with alcoholic hepatitis, heavy drinkers without liver disease, and healthy controls. The study aims to better understand how inflammation and mitochondrial function in Peripheral Blood Mononuclear Cells PBMCs contribute to alcoholic liver disease progression. This observational study involves comparing biological responses among these groups. Participants will provide blood samples, with 50 milliliters collected for analysis. No treatments or interventions are given the study focuses on blood draws from alcoholic hepatitis patients, heavy drinkers, and healthy controls. The data collected will include mitochondrial respiration, cytokine response, fatty acid metabolism, glucose, and insulin levels. During the study, participants will have blood drawn for laboratory measurements. Researchers will quantify mitochondrial respiration within one day after sample collection. The study monitors participants through these assessments to explore differences in biological markers related to alcoholic hepatitis and heavy alcohol use. The total participation duration varies, with study completion expected by the end of 2028.
CONDITIONS
Brief Title
Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis
Research Team
A
Annette Bellar
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here